trans-Hinokiresinol

trans-Hinokiresinol
Product Name trans-Hinokiresinol
CAS No.: 17676-24-3
Catalog No.: CFN99834
Molecular Formula: C17H16O2
Molecular Weight: 252.3 g/mol
Purity: >=98%
Type of Compound: Lignans
Physical Desc.: Powder
Targets: Estrogen receptor | NOS | IL Receptor | TNF-α | Progestogen receptor | LTB4
Source: The barks of Cryptomeria japonica
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
Hinokiresinol is a novel inhibitor of LTB4 binding to the human neutrophils, it has antiallergic effect, it inhibits IgE-induced mouse passive cutaneous anaphylaxis reaction. Hinokiresinol (trans-hinokiresinol) and nyasol (cis-hinokiresinol) are estrogen agonists, they possess appreciable estrogen receptor binding activity, they can stimulate the proliferation of estrogen- dependent T47D breast cancer cells, and their stimulatory effects could be blocked by an estrogen antagonist. They have similar free radical scavenging and anti-inflammatory activities, they also have anti-ischemic effects, only trans-hinokiresinol can significantly decrease neuronal injury in cultured cortical neurons exposed to oxygen-glucose deprivation followed by re-oxygenation.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Evid-Based Compl Alt2020, 7202519:13
  • Int Immunopharmacol.2019, 71:361-371
  • Anticancer Res.2021, 41(3):1357-1364.
  • Cell Signal.2022, 99:110433.
  • Toxicol In Vitro.2023, 93:105667.
  • Molecules.2019, 24(11):E2102
  • Front Pharmacol.2023, 14:1095083.
  • Biochemistry.2018, 57(40):5886-5896
  • Chem Biol Interact.2016, 258:59-68
  • HIV Med.2021, 22(8):690-704.
  • trans-Hinokiresinol

    Catalog No: CFN99834
    CAS No: 17676-24-3
    Price: Inquiry(manager@chemfaces.com)
    Agatharesinol

    Catalog No: CFN97696
    CAS No: 7288-11-1
    Price: Inquiry(manager@chemfaces.com)
    Agatharesinol acetonide

    Catalog No: CFN97675
    CAS No: 800389-33-7
    Price: Inquiry(manager@chemfaces.com)
    Sequirin C

    Catalog No: CFN97801
    CAS No: 18194-29-1
    Price: Inquiry(manager@chemfaces.com)
    Sequosempervirin B

    Catalog No: CFN97905
    CAS No: 864719-17-5
    Price: Inquiry(manager@chemfaces.com)
    Sequosempervirin D

    Catalog No: CFN97603
    CAS No: 864719-19-7
    Price: Inquiry(manager@chemfaces.com)
    Metasequirin D

    Catalog No: CFN97909
    CAS No: 1264694-96-3
    Price: Inquiry(manager@chemfaces.com)
    Chem Pharm Bull (Tokyo). 2000 Mar;48(3):389-92.
    Stereochemistry of cis- and trans-hinokiresinol and their estrogen-like activity.[Pubmed: 10726863]
    Naturally occurring phenylpropanoids, hinokiresinol (trans-Hinokiresinol) and nyasol (cis-hinokiresinol) were found to possess appreciable estrogen receptor binding activity.
    METHODS AND RESULTS:
    Strong differences in activity were observed between the geometrical isomers and enantiomers. Among these, (3S)-cis-hinokiresinol displayed the highest activity, one order of magnitude greater than the activity of genistein. Furthermore, cis- and trans-Hinokiresinol stimulated the proliferation of estrogen-dependent T47D breast cancer cells, and their stimulatory effects were blocked by an estrogen antagonist, indicating that the compounds are estrogen agonists. In addition, the absolute configuration of C-3 in (+)-cis-hinokiresinol has been assigned as S by comparison with the circular dichroism spectra of the hydrogenated products prepared from cis and trans ((3S)-trans-Hinokiresinol: previously assigned) isomers.
    CONCLUSIONS:
    These results incidentally provide us with an unambiguous answer to contradictory reports regarding the assignment of the full stereochemisry of cis- and trans-Hinokiresinol that have existed in the literature for more than two decades.
    Neuropharmacology. 2013 Apr;67:465-75.
    Differential anti-ischemic efficacy and therapeutic time window of trans- and cis-hinokiresinols: stereo-specific antioxidant and anti-inflammatory activities.[Pubmed: 23287539]
    During cerebral ischemia, neurons are injured by various mechanisms including excitotoxicity, oxidative stress, and inflammatory responses. Thus, pharmacological manipulation of multiple cytotoxic pathways has been pursued for the treatment of ischemic injury. Cis-hinokiresinol, a naturally occurring phenylpropanoid, was previously reported to possess anti-oxidant, anti-inflammatory and estrogen-like activities.
    METHODS AND RESULTS:
    In the present study, we investigated anti-ischemic effects of trans- and cis-hinokiresinols using in vitro as well as in vivo experimental models. The ORAC and DPPH assays showed that two isomers had similar free radical scavenging activities. However, only trans-Hinokiresinol significantly decreased neuronal injury in cultured cortical neurons exposed to oxygen-glucose deprivation (75 min) followed by re-oxygenation (9 h). The differential neuroprotective effect could be due to the stereo-specific augmentation of Cu/Zn-SOD activity by trans-Hinokiresinol, when compared with cis-hinokiresinol. Similarly, in rats subjected to transient middle cerebral artery occlusion (1.5 h) followed by 24-h reperfusion, pre-ischemic treatment with trans-Hinokiresinol, but not with cis-isomer, reduced cerebral infarct volume. Interestingly, however, post-ischemic treatment with both hinokiresinols (2 and 7 h after onset of ischemia) significantly reduced cerebral infarct. When administered after onset of ischemia, trans-Hinokiresinol, but not its cis-isomer reduced nitrotyrosine immunoreactivity in ischemic regions. In contrast, both hinokiresinols suppressed neutrophil infiltration and IL-1β release to a similar extent.
    METHODS AND RESULTS:
    The observed differential anti-oxidant, but comparable anti-inflammatory, activities may explain the stereo-specific anti-ischemic activities and different therapeutic time windows of the hinokiresinols examined. More detailed delineation of the anti-ischemic mechanism(s) of hinokiresinols may provide a better strategy for development of efficacious regimens for cerebral ischemic stroke.
    Phytomedicine. 2007 Oct;14(10):675-80.
    Effects of Chamaecyparis formosensis Matasumura extractives on lipopolysaccharide-induced release of nitric oxide.[Pubmed: 17291735]

    METHODS AND RESULTS:
    Bioactivity-guided chromatographic fractionation and metabolite profiling coupled with spectroscopic analyses, including (1)H-NMR, (13)C-NMR analyses, identified six compounds: vanillin (1), 4-hydroxybenzaldehyde (2), trans-Hinokiresinol (3), taiwanin E (4), 4alpha-hydroxyeudesm- 11-en-12-al (5), savinin (6). All of these six compounds were the first identified and reported from this tree species. Compounds (1), (3) and (5) demonstrated significant NO inhibition effect through reduction of NO production in activated RAW 264.7 cells due to the suppression of iNOS gene expression: compounds that can selectively inhibit undesirable expression of iNOS are important as they may serve as potential cancer chemopreventatives.
    CONCLUSIONS:
    This study suggests that C. formosensis may have potential for use as a natural resource for human health care.
    Planta Med. 2006 Nov;72(14):1328-30.
    Hinokiresinol inhibits IgE-induced mouse passive cutaneous anaphylaxis reaction.[Pubmed: 17051467 ]
    The antiallergic effect of hinokiresinol(trans-Hinokiresinol) isolated from the whole plant of TRAPA Pseudoincisa S. at. Z. was measured in vitro and in vivo.
    METHODS AND RESULTS:
    Hinokiresinol(trans-Hinokiresinol) not only potently inhibited beta-hexosaminidase release from RBL-2H3 cells induced by IgE, with an IC50 value of 98 microM, but also inhibited the proinflammatory cytokines IL-6, IL-4 and TNF-alpha in RBL-2H3 cells stimulated by IgE. Orally and intraperitoneally administered hinokiresinol(trans-Hinokiresinol ) potently inhibited the passive anaphylaxis reaction in mice induced by IgE.
    Planta Med., 1999, 65(4):391.
    Hinokiresinol: A Novel Inhibitor of LTB 4 Binding to the Human Neutrophils[Pubmed: 10364852 ]
    Hinokiresinol(trans-Hinokiresinol): A Novel Inhibitor of LTB 4 Binding to the Human Neutrophils
    J Plant Physiol. 2006 Dec;163(12):1221-8.
    Hinokiresinol is not a precursor of agatharesinol in the norlignan biosynthetic pathway in Japanese cedar.[Pubmed: 16884819]
    The biosynthetic relationship between the two norlignans agatharesinol and trans-Hinokiresinol was investigated.
    METHODS AND RESULTS:
    Fresh sapwood sticks of Cryptomeria japonica were fed with stable isotope-labeled compounds, namely p-coumaryl alcohol-[9,9-(2)H], p-coumaryl alcohol-[9-(18)O] and trans-Hinokiresinol-[1-(2)H], and then incubated under high-humidity for approximately 20 days, during which the two norlignans were produced simultaneously. While trans-Hinokiresinol was strongly deuterium-labeled after feeding with p-coumaryl alcohol-[9,9-(2)H], agatharesinol was only lightly labeled after feeding with either p-coumaryl alcohol-[9,9-(2)H] or -[9-(18)O]. These results suggest that p-coumaryl alcohol, which is a precursor of hinokiresinol, is not involved in the biosynthesis of agatharesinol. Therefore, the norlignan carbon skeleton of agatharesinol must be framed from different types of phenylpropanoid monomers compared to those utilized by the trans-Hinokiresinol pathway. The biosynthesis of these two norlignans seems to branch at an early stage, i.e., before the framing of the norlignan carbon skeleton. Furthermore, agatharesinol was not labeled with deuterium after feeding with (2)H-labeled trans-Hinokiresinol, which has the simplest norlignan structure.
    CONCLUSIONS:
    This result strongly supports the suggestion that the conversion of trans-Hinokiresinol to agatharesinol is not part of the biosynthesis of norlignans and that early branching occurs instead.
    Naringin 4'-glucoside

    Catalog No: CFN95014
    CAS No: 17257-21-5
    Price: $338/5mg
    3'-Hydroxymirificin

    Catalog No: CFN95102
    CAS No: 168035-02-7
    Price: $338/5mg
    1,7-Diphenyl-5-hydroxy-4,6-hepten-3-one

    Catalog No: CFN95171
    CAS No: 87095-77-0
    Price: $318/10mg
    Arisanschinin E

    Catalog No: CFN95221
    CAS No: 1333378-33-8
    Price: Inquiry(manager@chemfaces.com)
    Geoside

    Catalog No: CFN95233
    CAS No: 585-90-0
    Price: $368/5mg
    (+)-Lariciresinol 4'-O-beta-D-Glucopyranosyl-(1->3)-beta-D-glucopyranoside

    Catalog No: CFN95283
    CAS No: 639857-95-7
    Price: $463/5mg
    Cannabisin A

    Catalog No: CFN95287
    CAS No: 130508-46-2
    Price: $318/5mg
    Isosilychristin

    Catalog No: CFN95369
    CAS No: 77182-66-2
    Price: $318/5mg
    Lariciresinol 4-O-glucoside

    Catalog No: CFN95389
    CAS No: 143663-00-7
    Price: $318/5mg
    Mahuannin J

    Catalog No: CFN95533
    CAS No: N/A
    Price: $318/5mg